How does CTTH's PB Ratio compare to its peers?

Insufficient data to calculate CTTH's Price-To-Book Ratio vs. peers for valuation analysis.

How does CTTH's PB Ratio compare vs other companies in the US Pharmaceuticals Industry?

Insufficient data to calculate CTTH's Price-To-Book Ratio vs. industry for valuation analysis.

What is CTTH's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate CTTH's Price-To-Book Fair Ratio for valuation analysis.

What is the Fair Price of CTTH when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Insufficient data to calculate CTTH's fair value for valuation analysis.

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

CTTH Stock Overview

Engages in the development of oral drug delivery systems for pain management and treatment. More details

CTTH fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Latest financial reports are more than a year old

Does not have a meaningful market cap ($3M)

Highly volatile share price over the past 3 months compared to the US market

Shareholders have been diluted in the past year

My Notes

Capture your thoughts, links and company narrative

CTT Pharmaceutical Holdings, Inc. Competitors

Petros Pharmaceuticals

NasdaqCM:PTPI

US$3.8m

Sonoma Pharmaceuticals

NasdaqCM:SNOA

US$3.5m

Avenue Therapeutics

NasdaqCM:ATXI

US$3.5m

TNF Pharmaceuticals

NasdaqCM:TNFA

US$3.5m

Price History & Performance

Summary of share price highs, lows and changes for CTT Pharmaceutical Holdings
Historical stock prices
Current Share Price	US$0.064
52 Week High	US$0.10
52 Week Low	US$0.01
Beta	0
1 Month Change	29.89%
3 Month Change	5.92%
1 Year Change	62.95%
3 Year Change	58.88%
5 Year Change	-64.73%
Change since IPO	-84.87%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	CTTH	US Pharmaceuticals	US Market
7D	7.5%	0.5%	-2.1%
1Y	62.9%	2.3%	21.3%

Return vs Industry: CTTH exceeded the US Pharmaceuticals industry which returned 2.3% over the past year.

Return vs Market: CTTH exceeded the US Market which returned 21.3% over the past year.

Price Volatility

Is CTTH's price volatile compared to industry and market?
CTTH volatility
CTTH Average Weekly Movement	21.4%
Pharmaceuticals Industry Average Movement	11.1%
Market Average Movement	6.4%
10% most volatile stocks in US Market	18.9%
10% least volatile stocks in US Market	3.2%

Stable Share Price: CTTH's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: CTTH's weekly volatility has decreased from 59% to 21% over the past year, but is still higher than 75% of US stocks.

About the Company

Founded	Employees	CEO	Website
n/a	n/a	Ryan Khouri	www.cttpharmaceuticals.com

CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. It focuses on fast dissolving drug delivery systems. The company’s technology platform includes the development of advanced oral delivery thin wafers infused with both natural and/or synthetic cannabis extracts to deliver treatment as an alternate to smoking and ingestion.

CTT Pharmaceutical Holdings, Inc. Fundamentals Summary

How do CTT Pharmaceutical Holdings's earnings and revenue compare to its market cap?
CTTH fundamental statistics
Market cap	US$3.42m
Earnings (TTM)	-US$1.67m
Revenue (TTM)	n/a

0.0x

P/S Ratio

0.0x

P/E Ratio

Is CTTH overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CTTH income statement (TTM)
Revenue	US$0
Cost of Revenue	US$0
Gross Profit	US$0
Other Expenses	US$1.67m
Earnings	-US$1.67m

Last Reported Earnings

Sep 30, 2015

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did CTTH perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/12 19:09
End of Day Share Price	2025/01/10 00:00
Earnings	2015/09/30
Annual Earnings	2014/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

CTT Pharmaceutical Holdings, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution